KIMBERLY YOES: Open Payments
NPI 1902945330 · PORT NECHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 38 payments from 9 companies in 2025. Trend: 2023 $589 · 2024 $590 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $207 |
| Novo Nordisk Inc | 6 | $113 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| PFIZER INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: QULIPTA, Wegovy, UBRELVY, VRAYLAR, ZORYVE, Auvelity, CAPLYTA, Rybelsus.
Industry payments across TX — which companies pay providers there.
